Perihematoma Edema: A Potential Translational Target in Intracerebral Hemorrhage?

Translational Stroke Research

Volumn 6, Issue 2, 2015, Pages 104-106

  Selim, Magdy ^a   Sheth, Kevin N ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b YALE NEW HAVEN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITICOLINE; DEFEROXAMINE MESYLATE; DISUFENTON SODIUM; FINGOLIMOD; GAVESTINEL; GLYCEROL; HEMOGLOBIN; MANNITOL; PIOGLITAZONE;

APOPTOSIS; AUTOPHAGY; BLOOD CLOT RETRACTION; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN SIZE; BRAIN WATER; CELL SWELLING; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; EDEMA; EDITORIAL; HUMAN; ION TRANSPORT; NECROSIS; NEUROIMAGING; OXIDATIVE STRESS; PERIHEMATOMA EDEMA; PRIORITY JOURNAL; COMPLICATION;

BRAIN EDEMA; CEREBRAL HEMORRHAGE; HUMANS; NEUROIMAGING;

EID: 84925507137     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0389-7     Document Type: Editorial

References (24)

1. Lok J, Leung W, Murphy S, Butler W, Noviski N, Lo EH. Intracranial hemorrhage: mechanisms of secondary brain injury. Acta Neurochir Suppl. 2011;111:63–1169.
2. Chen S, Yang Q, Chen G, Zhang JH. An update on inflammation in the acute phase of intracerebral hemorrhage. Transl Stroke Res. 2014 [Epub ahead of print].
3. Hatakeyama T, Okauchi M, Hua Y, Keep RF, Xi G. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res. 2013;4(5):546–53. doi:10.1007/s12975-013-0270-5.
4. Li N, Worthmann H, Heeren M, Schuppner R, Deb M, Tryc AB, et al. Pattern of cytotoxic edema in the perihematomal region after intracerebral hemorrhage: a serial magnetic resonance imaging study. Stroke. 2013;44(4):1144–6.
5. Ayer A, Hwang BY, Appelboom G, Connolly Jr ES. Clinical trials for neuroprotective therapies in intracerebral hemorrhage: a new roadmap from bench to bedside. Transl Stroke Res. 2012;3(4):409–17.
6. Haley Jr EC, Thompson JL, Levin B, Davis S, Lees KR, Pittman JG, et al. GAIN Americas and GAIN International Investigators. Gavestinel does not improve outcome after acute intracerebral hemorrhage: an analysis from the GAIN International and GAIN Americas studies. Stroke. 2005;36(5):1006–10.
7. Lyden PD, Shuaib A, Lees KR, Davalos A, Davis SM, Diener HC, et al. Safety and tolerability of NXY-059 for acute intracerebral hemorrhage: the CHANT Trial. Stroke. 2007;38(8):2262–9.
8. Secades JJ, Alvarez-Sabin J, Rubio F, Lozano R, Davalos A, Castillo J. Citicoline in intracerebral haemorrhage: a double-blind, randomized, placebo-controlled, multi-centre pilot study. Cerebrovasc Dis. 2006;21:380–5.
9. Misra UK, Kalita J, Ranjan P, Mandal SK. Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci. 2005;234:41–5.
10. Yu YL, Kumana CR, Lauder IJ, Cheung YK, Chan FL, Kou M, et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke. 1992;23:967–71.
11. Fu Y, Hao J, Zhang N, Ren L, Sun N, Li YJ, et al. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study. JAMA Neurol. 2014;71(9):1092–101.
12. Gonzales NR, Shah J, Sangha N, Sosa L, Martinez R, Shen L, et al. Design of a prospective, dose-escalation study evaluating the Safety of Pioglitazone for Hematoma Resolution in Intracerebral Hemorrhage (SHRINC). Int J Stroke. 2013;8(5):388–96.
13. Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013;19(2):257–66.
14. Zazulia AR, Videen TO, Diringer MN, Powers WJ. Poor correlation between perihematomal mri hyperintensity and brain swelling after intracerebral hemorrhage. Neurocrit Care. 2011;15(3):436–41.
15. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5:53–63.
16. Venkatasubramanian C, Mlynash M, Finley-Caulfield A, Eyngorn I, Kalimuthu R, Snider RW, et al. Natural history of perihematomal edema after intracerebral hemorrhage measured by serial magnetic resonance imaging. Stroke. 2011;42:73–80.
17. Staykov D, Wagner I, Volbers B, Hauer EM, Doerfler A, Schwab S, et al. Natural course of perihemorrhagic edema after intracerebral hemorrhage. Stroke. 2011;42(9):2625–9.
18. McCarron MO, Hoffmann KL, DeLong DM, Gray L, Saunders AM, Alberts MJ. Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology. 1999;53(9):2176–9.
19. Sykora M, Diedler J, Turcani P, Rupp A, Steiner T. Subacute perihematomal edema in ICH is associated with impaired blood pressure regulation. J Neurol Sci. 2009;284(1–2):108–12.
20. Inaji M, Tomita H, Tone O, Tamaki M, Suzuki R, Ohno K. Chronological changes of perihematomal edema of human intracerebral hematoma. Acta Neurochir Suppl. 2003;86:445–8.
21. Sansing LH, Messe SR, Cucchiara BL, Lyden PD, Kasner SE. Anti-adrenergic medications and edema development after intracerebral hemorrhage. Neurocrit Care. 2011;14(3):395–400.
22. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke. 1999;30(6):1167–73.
23. Gebel Jr JM, Jauch EC, Brott TG, Khoury J, Sauerbeck L, Salisbury S, et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke. 2002;33:2631–5.
24. Urday S, Beslow LA, Vashkevich A, Ayres AM, Battey TWK, Selim MH, et al. Rate of peri-hematomal edema expansion predicts mortality after intracerebral hemorrhage. Ann Neurol. 2014;(SI:M1223). S 18(76): S88.